WASHINGTON —On this first day of Women’s History Month, the Department of Veterans Affairs (VA) launched efforts to increase women Veteran participation in VA’s Million Veteran Program (MVP) to aid in genetic research focused on women health issues.

MVP is currently researching genetic and clinical markers to predict breast cancer risk in women Veterans.

 

“While there are roughly 2 million living women Veterans, only 75,000 are currently enrolled in MVP representing only 9% of the MVP cohort,” said VA Assistant Secretary Public and Intergovernmental Affairs Kayla Williams, who is also an MVP participant. “If more women Veterans consider joining, VA researchers would have a larger gene pool to be able to study women’s health in greater detail and offer women the specialized care they need and deserve.”

With increased participation, research could focus on investigating treatments and preventions of diseases that affect women Veterans including depression, hypertension, heart disease, osteoarthritis and others.

Since 2011 more than 830,000 Veterans have joined MVP, allowing researchers to learn how differences in genes, lifestyle and military experiences affect Veterans’ health and illnesses.

Participation in MVP is entirely voluntary and Veterans go through an informed consent process to ensure MVP is right for them.

Learn more about enrolling in MVP on their website or by calling 866-441-6075. For more information about VA research, including MVP research program, visit VA’s Office of Research and Development.

###

Reporters and media outlets with questions or comments should contact the Office of Media Relations at vapublicaffairs@va.gov

Veterans with questions about their health care and benefits (including GI Bill). Questions, updates and documents can be submitted online.

Contact us online through Ask VA

Veterans can also use our chatbot to get information about VA benefits and services. The chatbot won’t connect you with a person, but it can show you where to go on VA.gov to find answers to some common questions.

Learn about our chatbot and ask a question

Subscribe today to receive these news releases in your inbox.

More from the Press Room